Abstract
Previously, the STAND program demonstrated improved HbA1c and exercise self-efficacy when patients with T2DM utilized the immediate blood glucose feedback of flash glucose sensing technology. However, when the STAND program was halted due to COVID-19, we sought to understand the feasibility of virtually delivering a group-based lifestyle medicine program using wearable technologies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
